EPO Patents = 2

Forward Citations = 0

Loading Chart...

24 inventors (with patents filed for the assignee):

Qingsong Liu (4 out of 13 patents)

Aoli Wang (4 out of 7 patents)

Ziping Qi (4 out of 7 patents)

4. Wenchao Wang (4 out of 11 patents)

5. Beilei Wang (4 out of 12 patents)

6. Jing Liu (4 out of 20 patents)

7. Li Wang (4 out of 17 patents)

8. Hong Wu (3 out of 6 patents)

9. Chen Hu (3 out of 9 patents)

10. Cheng Chen (3 out of 13 patents)

11. Fengming Zou (3 out of 5 patents)

12. Xixiang Li (2 out of 3 patents)

13. Jiaxin Wu (2 out of 3 patents)

14. Tao Ren (1 out of 6 patents)

15. Feiyang Liu (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 10975082 - Inhibitor of FLT3 kinase and use thereof (2021-04-13),

2. 10793543 - Selective C-KIT kinase inhibitor (2020-10-06),

3. 10781214 - Kinase inhibitor against wild-type and mutant EGFR (2020-09-22),

4. 10350210 - EGFR and ALK dual inhibitor (2019-07-16),

Precedo Pharmaceuticals Co., Ltd is a leading pharmaceutical company focused on developing innovative therapies to address unmet medical needs. With a strong commitment to research and development, we strive to improve the lives of patients worldwide. Our diverse portfolio includes medications for various therapeutic areas such as oncology, neurology, and infectious diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#26 in Anhui

#5,594 in China

Anhui, China

Precedo Pharmaceuticals Co., Ltd